Results 161 to 170 of about 14,780,959 (374)
Closed solutions to a differential-difference equation and an associated plate solidification problem. [PDF]
Layeni OP, Akinola AP, Johnson JV.
europepmc +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi +12 more
wiley +1 more source
Eventually periodic solutions of a max-type difference equation. [PDF]
Sun T, Liu J, He Q, Liu XH, Tao C.
europepmc +1 more source
On the Convergence of a Solution of a Difference Equation to a Solution of the Equation of Diffusion [PDF]
M. L. Juncosa, David Young
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
An energy stable fourth order finite difference scheme for the Cahn-Hilliard equation [PDF]
Kelong Cheng +3 more
semanticscholar +1 more source
A NONLINEAR DIFFERENTIAL-DIFFERENCE EQUATION OF GROWTH
W. J. Cunningham
openalex +1 more source
The use of large intervals in finite-difference equations [PDF]
L. Fox
openalex +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source

